Related Experiment Video
Updated: May 18, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Biomarkers in clinical medicine
Xiao-He Chen1, Shuwen Huang, David Kerr
1University of Oxford, Oxford, UK. xiao-he.chen@ndcls.ox.ac.uk
Biomarkers, objectively measured health indicators, are revolutionizing medicine. Advances in molecular biology enable their use in early disease detection, treatment, and prognosis across various medical fields.
Area of Science:
- Biomarker research and application in molecular biology and clinical medicine.
Background:
- Biomarkers have a long history in clinical medicine.
- Recent advances in genomics and molecular biology have propelled biomarker studies into a new era.
- Biomarkers are crucial for early diagnosis and effective disease treatment.
Purpose of the Study:
- To define biomarkers and their five categories based on disease stages: antecedent, screening, diagnostic, staging, and prognostic.
- To explore the diverse applications of biomarkers in preventive medicine, diagnostics, therapeutics, and prognostics.
- To discuss the current status and public health implications of biomarker utilization in clinical practice.
Main Methods:
- The chapter defines biomarkers as objectively measured characteristics indicating biological processes or therapeutic responses.
- Biomarkers are classified into five categories based on their role in disease management.
- The review focuses on the application of biomarkers in preventive medicine, diagnostics, therapeutics, prognostics, and public health.
Main Results:
- Biomarkers serve as indicators of normal biological processes, disease states, or treatment efficacy.
- They can identify risks, screen for subclinical disease, diagnose overt disease, stage severity, and predict prognosis.
- Biomarkers reflect exposures, genetic susceptibility, and responses to interventions.
Conclusions:
- Biomarkers are essential tools in modern medicine, offering insights from disease risk assessment to treatment monitoring.
- Their classification aids in understanding their diverse roles across the entire spectrum of healthcare.
- The integration of biomarkers into clinical practice and public health is expanding due to technological advancements.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Measurement of Bioavailability: Pharmacodynamic Methods
Clinical Trials
There are four phases in a clinical trial. A phase one...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Automated Microbial Diagnostics
